01Start with the document's definition of the blend

The supplied example is report MA-PEP-0042, revision 01, lot PEP-42-7LP. It describes a 10 mg vial labelled as 5 mg BPC-157 plus 5 mg TB-500, with TB-500 explicitly identified in this document as Ac-LKKTETQ. Preserve that sequence-level qualification when discussing this example; the short name alone is less specific.Blend report (PDF) (opens in a new tab)

This matters when comparing documents or research papers. A familiar blend name is not enough to establish that the same molecular entities and proportions are being discussed. Record each named component, any sequence or modification the document supplies, and the labelled amount assigned to it.

The report records an identity conclusion against references using LC-HRMS. That is a statement about the identity work described in the document. It should not be expanded into a claim about every alternative structure or every product elsewhere sold under the same short names.Blend report (PDF) (opens in a new tab)

02Read the individual amounts before adding them

Both displayed results lie within their respective ranges. Adding them gives 10.00 mg. This total is our calculation from the two reported assays; it does not replace the individual entries. Relative to that calculated total, the reported amounts correspond to 50.2% and 49.8% by mass.

Those percentages describe the ratio between the two reported component amounts. They are not percentages of all physical material in the vial, and they are not chromatographic area percentages. Nor are they a molar ratio: converting mass to amount of substance would require the appropriate molecular-mass basis for each component.

03What does combined purity describe here?

The document reports combined chromatographic purity of 99.52%, a largest impurity of 0.14% and total related substances of 0.48%. Its trace notes assign the combined area to the two target peaks. Read “combined” as the report defines it, rather than treating the number as a separate purity result of 99.52% for each component.Blend report (PDF) (opens in a new tab)

The combined area figure cannot reveal the 5.02-to-4.98 mass relationship on its own. The individual assay entries supply that information. In particular, two similar-looking target peaks do not justify assuming an equal mass blend without an appropriate quantitative basis.

04Check the notes that qualify the table

The supplied report lists related peaks A–F without structural assignments and gives a reporting threshold of 0.03%. Do not supply chemical identities for those lettered peaks from guesswork. The document also refers to duplicate independent preparations; that does not, by itself, establish how many separate vials were sampled across the lot.Blend report (PDF) (opens in a new tab)

If a component assay is absent from another blend certificate, a total-content result cannot recover it. Ask whether each target was measured separately, which reference was used and how the result is expressed. If the answer is unavailable, keep the component amount as an unresolved measurement rather than copying the label claim into the results column.

05Keep the conclusion analytical

A concise record for this example can state the two named components, their reported amounts, the calculated sum and the combined area-purity result. Keep the lot and report revision with that record. This preserves the blend-specific evidence without making the total carry more meaning than it has.

The report does not test whether the components have beneficial combined effects in a biological system. Composition measurements cannot establish synergy, clinical outcomes or suitability for human use. Questions about experimental interactions require evidence from the relevant research model, separate from a certificate.